MYRIAD GENETICS, INC.

Sector ratings Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
12.39 ^USD	-1.04%		-16.45%	-9.63%

Jan. 15	Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM
Jan. 15	Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Fundamentals	Composite Valuation	Composite Consensus	Composite Momentum	Composite Visibility	Investor Rating	ESG MSCI	Capi. ($)
	MYRIAD GENETICS, INC.							A	1.13B
	BIOMÉRIEUX							AA	13.43B
	SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.							BBB	6.56B
	LANTHEUS HOLDINGS, INC.		-					BBB	6.36B
	DIASORIN S.P.A.							BBB	5.59B
	GUARDANT HEALTH, INC.		-					AA	4.53B
	AUTOBIO DIAGNOSTICS CO., LTD.							CCC	3.13B
	VITROLIFE AB							A	2.52B
	10X GENOMICS, INC.		-					BBB	1.83B
	SANSURE BIOTECH INC.		-					-	1.55B
	GUANGZHOU WONDFO BIOTECH CO.,LTD		-					-	1.44B
	VCANBIO CELL & GENE ENGINEERING CORP., LTD		-	-		-	-	-	1.22B
	AMOY DIAGNOSTICS CO., LTD.							-	1.16B
	MACCURA BIOTECHNOLOGY CO.LTD							-	1.04B
	BEIJING STRONG BIOTECHNOLOGIES,INC.		-					-	1.03B
	SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.							-	830M
	Average							A	3.33B
	Weighted average by Cap.							A

Diagnostic & Testing Substances